Showing results (371-380 of 675) with videos related to

Sort By:
Pageof 68
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
The New England Journal of Medicine|June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal womenPaul E Goss, James N Ingle, José E Alés-Martínez, et al.
Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.
Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Developmental Cell|May 26, 2022
A human breast atlas integrating single-cell proteomics and transcriptomicsG Kenneth Gray, Carman Man-Chung Li, Jennifer M Rosenbluth, et al.
Cancer Cell|March 14, 2007
Molecular definition of breast tumor heterogeneityMichail Shipitsin, Lauren L Campbell, Pedram Argani, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
Pageof 68